A detailed history of Eastern Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Eastern Bank holds 133,724 shares of ABBV stock, worth $26.4 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
133,724
Previous 130,296 2.63%
Holding current value
$26.4 Million
Previous $23.7 Million 3.33%
% of portfolio
0.96%
Previous 1.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$154.79 - $180.76 $530,620 - $619,645
3,428 Added 2.63%
133,724 $22.9 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $1.4 Million - $1.59 Million
8,743 Added 7.19%
130,296 $23.7 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $534,300 - $601,748
-3,883 Reduced 3.1%
121,553 $18.8 Million
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $35,534 - $41,136
266 Added 0.21%
125,436 $18.7 Million
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $2.64 Million - $3.28 Million
19,905 Added 18.91%
125,170 $16.9 Million
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $1.12 Million - $1.29 Million
7,758 Added 7.96%
105,265 $16.8 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $62,239 - $74,641
450 Added 0.46%
97,507 $0
Q3 2022

Oct 19, 2022

BUY
$134.21 - $153.93 $163,467 - $187,486
1,218 Added 1.27%
97,057 $13 Million
Q2 2022

Jul 20, 2022

BUY
$137.62 - $174.96 $10 Million - $12.7 Million
72,654 Added 313.37%
95,839 $14.7 Million
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $1.94 Million - $2.41 Million
14,713 Added 173.67%
23,185 $3.76 Million
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $11,709 - $14,816
109 Added 1.3%
8,472 $1.15 Million
Q2 2021

Jul 20, 2021

SELL
$105.21 - $117.21 $9,784 - $10,900
-93 Reduced 1.1%
8,363 $942,000
Q1 2021

Apr 27, 2021

SELL
$102.3 - $112.62 $55,139 - $60,702
-539 Reduced 5.99%
8,456 $915,000
Q4 2020

Jan 20, 2021

SELL
$80.49 - $108.67 $2,334 - $3,151
-29 Reduced 0.32%
8,995 $964,000
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $11,941 - $14,015
-139 Reduced 1.52%
9,024 $791,000
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $14,967 - $20,028
-204 Reduced 2.18%
9,163 $899,000
Q1 2020

Apr 27, 2020

SELL
$64.5 - $97.79 $36,184 - $54,860
-561 Reduced 5.65%
9,367 $714,000
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $138,705 - $173,550
-1,923 Reduced 16.23%
9,928 $879,000
Q3 2019

Nov 04, 2019

SELL
$62.98 - $75.72 $167,085 - $200,885
-2,653 Reduced 18.29%
11,851 $898,000
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $926,567 - $1.18 Million
-14,103 Reduced 49.3%
14,504 $1.05 Million
Q1 2019

Apr 18, 2019

SELL
$77.14 - $90.79 $9.9 Million - $11.6 Million
-128,280 Reduced 81.77%
28,607 $2.31 Million
Q4 2018

Jan 18, 2019

SELL
$77.85 - $96.01 $147,292 - $181,650
-1,892 Reduced 1.19%
156,887 $14.5 Million
Q3 2018

Oct 16, 2018

BUY
$88.91 - $98.84 $107,581 - $119,596
1,210 Added 0.77%
158,779 $15 Million
Q2 2018

Jul 18, 2018

BUY
$89.78 - $106.23 $447,104 - $529,025
4,980 Added 3.26%
157,569 $14.6 Million
Q1 2018

Apr 09, 2018

BUY
$92.01 - $123.21 $9.17 Million - $12.3 Million
99,675 Added 188.37%
152,589 $14.4 Million
Q4 2017

Jan 22, 2018

SELL
$89.56 - $98.21 $901,331 - $988,385
-10,064 Reduced 15.98%
52,914 $5.12 Million
Q3 2017

Oct 24, 2017

BUY
$69.85 - $89.22 $4.4 Million - $5.62 Million
62,978
62,978 $5.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Eastern Bank Portfolio

Follow Eastern Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.